TABLE 5.

Distribution of laboratory values according to the treatment received by the study group

	Treatment									Test value
	Favipiravir1			Favipiravir and Hydroxychloroquine2			Hydroxychloroquine3			P
	Median	25 th percent	75 th percent	Median	25 th percent	75 th percent	Median	25 th percent	75 th percent
First neutrophil %	62.15	54.80	70.20	63.75	57.35	71.20	57.50	49.00	68.20	.179
First lymphocyte %	26.55	17.50	33.30	23.25	16.75	31.95	26.35	19.30	34.90	.487
First NLR	2.45	1.69	3.65	3.02	1.91	3.80	2.24	1.57	3.58	.286
First platelet	224.00	191.00	283.00	221.50	182.00	255.00	250.00	212.00	290.00	.066
First D‐dimer	0.45	0.26	0.83	0.54	0.35	0.99	0.26	0.19	0.45	<.001
First ferritin	62.90	19.10	211.00	120.40	41.20	262.00	104.50	27.35	182.50	.389
First CRP	13.00	4.00	44.33	9.20	3.19	23.20	3.31	1.44	7.77	<.001
After 1 month neutrophil %	57.40	52.50	65.80	60.00	49.50	65.85	59.80	52.70	64.70	.964
After 1 month lymphocyte %	25.85	17.95	32.70	24.55	18.75	33.35	31.40	26.00	36.20	.005
After 1 month NLR	2.29	1.62	3.21	2.28	1.54	3.38	1.96	1.46	2.47	.053
After 1 month platelet	282.00	232.50	343.50	267.00	229.00	337.00	244.00	221.00	291.50	.058
After 1 month D‐dimer	0.42	0.30	0.80	0.46	0.31	0.68	0.30	0.19	0.55	.014
After 1 month ferritin	73.00	22.00	265.00	57.00	29.10	194.00	48.55	11.00	157.35	.382
After 1 month CRP	0.40	0.00	4.50	3.29	0.87	7.00	0.54	0.00	2.27	<.001

Kruskal‐Wallis Test was used. First D‐dimer 1‐2:0.357 1‐3:<0.001 2‐3:<0.001, First CRP 1‐2:0.422 1‐3: <0.001 2‐3:0.058, After 1 mo D‐dimer 1‐2:1.000 1‐3:0.024 2‐3:0.033, After 1 mo CRP 1‐2:<0.001 1‐3:1.000 2‐3: <0.001.

Abbreviations: CRP, C‐reactive protein; NLR, neutrophil/lymphocyte ratio.